POLYMERASE EXTENSION AT 3' TERMINUS OF PNA-DNA CHIMERA

Abstract: The invention provides methods and a kit for primer extension of PNA-DNA chimera from template nucleic acids using polymerases, nucleotide 5'-triphosphates, and primer extension reagents. Structural requirements of the chimera for primer extension include 5 to 15 contiguous PNA monomer units, 3 or more contiguous nucleotides, and a 3' hydroxyl terminus. The chimera and/or a nucleotide is labelled with the fluorescent dyes or other labels. The methods include DNA sequencing, DNA fragment analysis, reverse transcription, mini-sequencing, chromosome labelling, amplification, and single nucleotide polymorphism (SNP) detection.

Description: POLYMERASE EXTENSION AT 3' TERMINUS OF PNA-DNA CHIMERA I. FIELD OF THE INVENTION The invention relates generally to the fields of enzymology and nucleic acid analogs Specifically, this invention is directed to template-dependent, pπmer extension of PNA-DNA chimera using polymerase enzyme and nucleotide 5'-tπphosphates II. BACKGROUND One of the most powerful and versatile tools available to molecular biologists is the in vitro replication of nucleic acid sequences by pπmer extension, as exemplified by the ubiquitous techniques of polymerase chain reaction (PCR) (Mulhs, 1987) and DNA sequencing (Sanger, 1977) Both techniques include the steps of 1) hybπdizmg a short, e.g 15-30 nt, synthetic oligonucleotide pπmer to a single-stranded template nucleic acid, and 2) enzymatically extending from the 3' hydroxyl terminus of the pπmer in the presence of nucleotide 5'-tπphosphates, complementary to the template strand, and a polymeπzmg enzyme. By this general pπmer extension method, sequencing information is generated, template nucleic acids are amplified or copied, and other genetic analysis tests are conducted. Results are optimized through the choice and concentrations of pπmers, multiple pπmers, enzymes, nucleotides, and other reagents, and the selection of temperature, temperature cycling conditions, and other expenmental conditions The choice of pπmers has been pπmaπly limited to 2'-deoxyolιgonucleotιde pπmers made by the phosphoramidite chemistry method (Caruthers, 1983) on automated synthesizers (Caruthers, 1984) Whereas nucleic acid analogs are known which efficiently hybπdize to DNA or RNA, some with comparable or supeπor hybπdization specificity and/or affinity, enzyme-mediated formation of a new phosphodiester bond only occurs between a pπmer having a 3' terminal hydroxyl and a nucleotide having a 5'- tπphosphate, or a closely related isostere, l e α-thiotπphosphate, etc Most structural permutations in either the pπmer or the nucleotide severely compromise the efficiency of pπmer extension, or negate it totally Nucleic acid analogs are structural analogs of DNA and RNA and which are designed to hybπdize to complementary nucleic acid sequences Through modification of the internucleotide linkage, the sugar, and or the nucleobase, nucleic acid analogs may attain any or all of the following desired properties 1 ) optimized hybπdization specificity or affinity, 2) nuclease resistance, 3) chemical stability, 4) solubility. 5) membrane- permeability, and 6) ease or low costs of synthesis and purification A useful and accessible class of nucleic acid analogs is the family of peptide nucleic acids (PNA) in which the sugar/phosphate backbone of DNA or RNA has been replaced with acyclic, achiral, and neutral polyamide linkages The 2-amιnoethylglycιne polyamide linkage m particular has been well-studied and shown to impart exceptional hybπdization specificity and affinity when nucleobases are attached to the linkage through an amide bond (Buchardt, 1992, Nielsen, 1991 ) 2-Ammoethylglycme PNA ohgomers (Figure 1A) typically have greater affinity, l e hybπdization strength and duplex stability for their complementary PNA, DNA and RNA, as exemplified by higher thermal melting values (Tm), than the corresponding DNA sequences The melting temperatures of PNA/DNA and PNA/RNA hybπds are much higher than corresponding DNA/DNA or DNA/RNA duplexes (generally 1 °C per bp) due to a lack of electrostatic repulsion m the PNA-contaimng duplexes Also, unlike DNA DNA duplexes, the Tm of PNA/DNA duplexes are largely independent of salt concentration The 2-ammoethylglycme PNA ohgomers also demonstrate a high degree of base-discnmination (specificity) in paiπng with their complementary strand Specificity of hybπdization can be measured by compaπng Tm values of duplexes having perfect Watson/Cπck complementaπty and those with one or more mismatches The degree of destabihzation of mismatches, measured by the decrease in Tm (ΔTm), is a measure of specificity In addition to mismatches, specificity and affinity are affected by structural modifications, hybπdization conditions, and other expeπmental parameters The neutral backbone of PNA also increases the rate of hybπdization significantly in assays where either the target, template, or the PNA probe is immobilized on a solid substrate Without any electrostatic repulsion, the rate of hybπdization is often much higher for PNA probes than for DNA or RNA probes in applications such as Southern blotting, northern blots, or in situ hybπdization expeπments (Corey, 1995) Unlike DNA, PNA can displace one strand, "strand invasion", of a DNA DNA duplex (Kuhn, 1999) With certain DNA sequences, a second PNA can further bind to form an unusually stable tπple helix structure (PNA) 2 /DNA PNA have been investigated as potential antisense agents, based on their sequence-specific inhibition of transcπption and translation (Von Matt, 1999; Lee. 1998; Nielsen. 1996). PNA ohgomers themselves are not substrates for polymerase as pπmers or templates, and do not conduct primer extension with nucleotides (Demers, 1997, see col. 2, lines 55-56). PNA-DNA chimera are oligomer molecules with discrete PNA and nucleotide moieties. They can be synthesized by covalently linking PNA monomers and nucleotides in virtually any combination or sequence. Efficient and automated methods have been developed for synthesizing PNA-DNA chimera (Vinayak, 1997; Uhlmann, 1996; Van der Laan, 1997). PNA-DNA chimera are designed to have desirable properties found in PNA and DNA, e.g. superior hybridization properties of PNA and biological functions like DNA (Uhlmann, 1998). Attempts to demonstrate primer extension of PNA-DNA chimeric primers with radioisotopically-labelled nucleotides have been reported. Primer extension on an 81nt DNA template was attempted from a complementary PNA-DNA chimera with 15 PNA monomer units linked through an amide bond to a single 3' terminal thymidine nucleoside (Figure IB), various polymerases, and nucleotides dATP, dGTP, dTTP, and 32 P-dCTP (Lutz, 1998). Some incorporation of nucleotides and extension may be evident, but due to the unavailability of proper control experiments, the level of incorporation is unknown. Primer extension was also reported using a mixture of PNA-DNA chimera consisting of 19 PNA monomer units with three (Figure ID) and four 2'- deoxynucleotides, labelled once and twice respectively, with 32 P dCTP and terminal transferase (Misra, 1998). The 3' hydroxyl terminus was extended on a 49nt DNA template and a 30nt RNA template with unlabelled nucleotide 5'-triphosphates. Autoradiography of the gel after electrophoresis showed a ladder of radiolabelled products, the majority of which was unextended chimera, indicating inefficient primer extension. This experiment employed a relatively long PNA moiety, 19 monomer units, incurring the attendant costs, loss of specificity, and synthesis inefficiencies of a longer chimera oligomer. In another study, chimera consisting of 3 PNA monomer units and either 2,4,6,9, or 12 deoxynucleotides were extended with Klenow polymerase from an 18nt DNA template (Reeve, 1995). All chimera had T deoxynucleotide at the linkage between the PNA and DNA moieties. Detection of incorporated 32 P-dCTP by autoradiography indicated that all the chimera except the one with 2 deoxynucleotides were extended. However, no quantitative or qualitative data was provided. Given the sensitivity of autoradiography, extension of the chimera in this study may have been at a detectable, but not useful, level. Fluorescence has largely supplanted radioactivity as the prefeπed detection method for most primer extension applications, such as automated DNA sequencing, in vitro DNA probe-based diagnostics, nucleic acid amplification, DNA fragment analysis, and transcriptional expression mapping and profiling. It is thus desirable to provide methods by which PNA-DNA chimera can be enzymatically extended to form non- radioisotopically labelled extension products. DNA sequencing methods benefit from the use of PNA-DNA chimera as primers, in particular where the template is double-stranded or where random priming is conducted with an array of a large number of chimera, or mixed-base sequence chimera. The increased affinity and specificity conferred by the PNA moiety in a PNA-DNA chimera allows for shorter primers. Shorter primers are more economical and require less sequence information. Such methods would improve assays and tests based on primer extension, e.g. greater precision and accuracy. III. SUMMARY The invention relates to chimera molecules of PNA and DNA monomer units and their use in primer-extension methods, such as DNA sequencing and nucleic acid amplification, to generate non-radioisotopically labelled extension products. The invention provides methods for enzymatic extension of PNA-DNA chimera primers to generate labelled primer extension products. The invention is based on the discovery that a PNA-DNA chimera can conduct primer extension under a broad range of experimental conditions and variables. PNA-DNA chimeras of the invention include two moieties covalently linked together: i) a contiguous moiety of 5 to 15 PNA monomer units, and ii) a contiguous moiety of at least three nucleotides. The nucleotide moiety has an enzymatically-extendable terminus, such that the PNA-DNA chimera can be enzymatically extended. In a first aspect, the invention provides a method of producing a template- dependent, non-radioisotopically labelled chimeric extension product by enzymatically extending a PNA-DNA chimera primer annealed to a template nucleic acid in the presence of a polymerase and a primer extension reagent (Figure 2). The primer extension reagent comprises a nucleotide 5'-triphosphate capable of supporting template-dependent extension. The chimera and/or the nucleotide 5'-triphosphate may be labelled with a non- radioisotopic label such that the extension products are non-radioisotopically labelled. In one illustrative embodiment of the invention, the PNA-DNA chimera has the formula P x - L - N y 3'. where each P is independently a PNA monomer, x is an integer from 5 to 15, L represents a covalent linkage between P and N, each N is independently a nucleotide, y is an integer from 3 to 15, and the 3' terminal N has a 3' hydroxyl group (Figure ID) In one embodiment of the method, the extension reagent compπses a mixture of nucleotide 5'-tπphosphates capable of incorporation and creation of an extended pπmer with a 3' hydroxyl, and capable of further, continuous extension, e g 2'- deoxyπbonucleotides (dNTP) and πbonucleotides (NTP) The reagent may further include one or more terminator nucleotides capable of incorporation, e g 2',3'- dideoxynucleotides (ddNTP) and 2,3'-dιdeoxy-dehydronucleotιdes, that, once incorporated, terminate further extension In another embodiment, the reagent compπses only terminator nucleotides and does not include nucleotide 5'-tπphosphates capable of continuous extension In a preferred embodiment, the PNA moiety, I e., P , of the PNA-DNA chimera is a 2-ammoethylglycme peptide nucleic acid The DNA moiety, i.e., N y , of the PNA-DNA chimera may be compπsed of 2'- deoxynucleotides (DNA), πbonucleotides (RNA), and modified sugars or mtemucleotide linkages thereof, especially those that confer greater specificity, affinity, rates of hybπdization, and chemical stability In embodiments employing a labelled PNA-DNA chimera, the PNA-DNA chimera may be labelled at. (l) a nucleobase, e g the N-9 or C-8 positions of a puπne or a deazapuπne nucleobase, or the C-5 position of a pyπmidme nucleobase, (n) a sugar; (in) the ammoethylglycme backbone, or (IV) an ammo, a sulfide, a hydroxyl, and/or a carboxyl group Preferably, the chimera is labelled at the ammo terminus of the PNA moiety In embodiments employing a labelled nucleotide, the nucleotide 5'-tπphosphate is preferably labelled at the nucleobase, but may also be labelled at other positions provided that the label does not interfere with enzymatic incorporation Labels may be fluorescent dyes (Figures 3A-3B), fluorescence quenchers (Figure 4), hybπdization- stabilizers, energy-transfer dye pairs, electrophoretic mobility modifiers, chemiluminescent dyes, ammo acids, proteins, peptides, enzymes, and affinity ligands. Preferably, the label is detectable upon illumination with light, e g laser sources at infrared, visible or ultraviolet excitation wavelengths The linkage, L, between the PNA and DNA moieties is preferably a bond, e g the carbonvl-nitrogen bond in an amide group where the moieties are linked without intervening atoms (Figures IB-ID) In another embodiment, the linkage may be a multi- atom linker, e g an alkyldiyl consisting of 1 to 20 carbon atoms, an aryldiyl consisting of 6 to 20 carbon atoms, optionally including one or more heteroatoms, O linker, or 1 to 6 ethyleneoxy units, -(CH 2 CH 2 O)- (Figures 6A-6B) The template or target nucleic acid can be any nucleic acid or nucleic acid analog capable of mediating template-directed nucleic acid synthesis Examples of suitable template nucleic acids include, e g , genomic DNA, DNA digests, plasmids, vectors, viral DNA, PCR products, RNA, and synthetic nucleic acids The template nucleic acid may also be a metaphase or mterphase chromosome Preferably, the chromosome is denatured pπor to PNA-DNA chimera hybπdization and pπmer extension Template nucleic acids may be single-stranded or double-stranded Templates are typically larger than the PNA- DNA chimera pπmer and can range from as few as about 20-30 to as many as millions of nucleotides (nt) or base-pairs (bp), depending on the particular application Suitable enzymes to extend the PNA-DNA chimera pπmers depend on the composition of the template nucleic acid Reverse transcπptases may be used for extending RNA templates, e.g. mRNA DNA polymerase may be used for extending DNA templates The template nucleic acid or the PNA-DNA chimera may be immobilized on a solid substrate When immobilized, the template or chimera is preferably covalently attached to the solid substrate, e g via a terminal monomer unit In a second aspect of the mvention, a kit for pπmer extension is provided which compπses (l) a PNA-DNA chimera having from 5 to 15 contiguous PNA monomer umts, from 3 to 15 contiguous nucleotides, and a 3' hydroxyl terminus, (n) one or more enzymatically extendable nucleotide 5'-tπphosphates and, (m) a polymerase enzyme. The chimera and/or a nucleotide 5'-tπphosphate is labelled with a non-radioisotopic label In another embodiment, the kit additionally includes a template compπsing a sequence complementary to the chimera or containing one or more mismatches to the chimera In a third aspect, the invention provides methods for sequencing a template nucleic acid by enzymatically extending a PNA-DNA chimera pπmer hybπdized to the template in the presence of a polymerase and a terminating nucleotide 5'-tπphosphate The chimera or the nucleotide 5'-tπphosphate is non-radioisotopically labelled Generally, the methods for sequencing a template nucleic acid compπse the steps of (l) generating a seπes of differently-sized pπmer extension products by enzymatically extending a PNA-DNA chimera annealed to the template nucleic acid in the presence of a polymerase, a mixture of nucleotide 5'-tπphosphates capable of supporting continuous pπmer extension and at least one terminating nucleotide 5'-tπphosphate, (n) separating the pπmer extension product from one another, typically based on size, and (in) determining the sequence of the template nucleic acid In one embodiment, a nested set of labelled pπmer extension products, 1 e a set in which each extension product is one nt shorter than the preceding extension product of the set, are generated by a mixture of enzymatically-extendable nucleotide 5'- tπphosphates capable of supporting continuous pπmer extension Where either the PNA- DNA chimera or the terminating nucleotide 5'-tπphosphate bears a non-radioisotopic label, the identity of certam bases is revealed by the labels, as is well known in the art of nucleic acid sequencing (Bergot, 1994, Lee, 1992, Smith, 1998) In one convenient embodiment, a mixture of four different labelled terminating nucleotides is used, e g ddATP, ddCTP, ddGTP, ddTTP, each beaπng a different, determinable label, such that the 3'-teπτunus nucleotide of each pπmer extension product is revealed by the identity of the label Alternatively, the method can be performed in the absence of nucleotide 5'- tπphosphates capable of supporting continuous pπmer extension such that only a single terminating nucleotide is added (Goelet, 1999, Syvanen, 1990) The methods of the present invention are well-suited to fluorescent detection, particularly the simultaneous detection of multiple spectrally-resolvable fluorescent dyes The methods are particularly well-suited for detecting, identifying, or determining classes of pπmer extension products that have been subjected to a separation procedure, such as electrophoresis, or that have been distπbuted amongst locations in a spatially-addressable hybπdization array In a fourth aspect, a method is provided for reverse transcπption of RNA by enzymatically extending a pπmer-template RNA hybπd m the presence of a reverse transcπptase and a mixture of enzymatically-extendable nucleotide 5'-tπphosphates capable of supporting continuous pπmer extension The pπmer is a PNA-DNA chimera and either said pπmer or a nucleotide 5'-tπphosphate is non-radioisotopically labelled In a fifth aspect, a method is provided for in situ chromosome targetting by single or multiple labelling where the chromosome is denatured and either in metaphase or mterphase A pπmer-chromosome hybπd is enzymatically extended in the presence of a DNA polymerase and a mixture of nucleotide 5'-tπphosphates capable of supporting continuous pπmer extension The pπmer is a PNA-DNA chimera Either the pπmer or a nucleotide 5'-tπphosphate is non-radioisotopically labelled Fluorescence at the chimera binding sites on the chromosome can be detected In a sixth aspect, a method is provided for DNA amplification where amplification products are generated by enzymatically extending a pπmer-template nucleic acid in the presence of two pπmers, a DNA polymerase and a mixture of enzymatically-extendable nucleotide 5 '-tπphosphates capable of supporting continuous pπmer extension One or both of the pπmers is a PNA-DNA chimera Either the pπmers or nucleotide 5'- tπphosphates are non-radioisotopically labelled The temperature is cycled to effect denaturation, annealing, and pπmer extension to form an amplification product by extension of the pπmers with the nucleotide 5 '-tπphosphates. One or both of the 5' terminn of the amplification product bears the PNA sequence of the chimera pπmers In one embodiment, the amplification product is immobilized by hybπdization on a solid substrate compπsmg a nucleic acid having a sequence complementary to the PNA moiety of the amplification product. These and other aspects, objects, features, and advantages of the present invention will become better understood with reference to the following descπption, drawings, examples, and appended claims. IV. BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 Structures of N-(2-ammoethyl)-glycιne PNA (1A) and PNA-DNA chimera with one (IB), two (1C), and three (ID) 2'-deoxynucleotιdes, where B is a nucleobase. The wavy line segment represents continuing, repeating units FIG. 2 Schematic of extension of PNA-DNA chimera on a template nucleic acid. FIG. 3 Fluorescent dye label structures: FAM, TET, HEX, JOE, NED, VIC (3A), dJON, dR139, JODA, FAM donor (3B). X denotes an attachment site. FIG. 4 Quencher label structures TAMRA, ROX, DABCYL, DABSYL, NTB. X denotes an attachment site X denotes an attachment site. Z is H or NO 2 FIG. 5 Linker reagents for linkers between PNA and DNA moieties in chimera. FIG 6 PNA-DNA chimera with bis-efhyleneoxy-acetamido linker (6A) and bis- ethyleneoxy-phosphate linker (6B). FIG. 7 Polyacrylamide (15%) gel electrophoresis under denatuπng conditions (7M urea) and SYBR-Green staining. Pπmer extension of a DNA 38nt template (SEQ. ID NO. 8) with vaπous pπmers. Top panel Klenow (exo-) polymerase, middle panel: Amp Taq FS polymerase, bottom panel: no enzyme Lane Pπmer (SEQ. ID NO.) 1 none 2 TAG TTC 1 3 TAG TTC - 1 2 4 TAG TTC - ta 3 5 TAG TTC - tag 4 6 TAG TTC - taga 5 7 5' tag ttc 3' 6 8 5' tag ttc tag 3' 7 M DNA oligo ladder PNA - UPPER CASE; DNA- lower case FIG. 8 Polyacrylamide (15%) gel electrophoresis under denaturing conditions (7M urea) and SYBR-Green staining. Primer extension of DNA 38nt template (SEQ. ID NO. 8) with PNA-DNA chimera with Klenow (exo-) polymerase Lane Primer (SEQ. ID NO.) 1 AC-TAG TTC T - • ag 9 2 AC-TAG TTC T - aga 10 3 AC-TAG TTC T • agac 11 FIG. 9 Polyacrylamide (15%) gel electrophoresis under denaturing conditions (7M urea) and SYBR-Green staining. Specificity of DNA and PNA-DNA chimera primers with Klenow (top gel) and Bst polymerase (bottom gel), and perfect match 38nt template (SEQ. ID NO. 8) (left side) and two mismatched templates (SEQ. ID NO. 12 and 13) (right side). Lane Primer (SEQ. ID NO.) 6/0 TAG TTC 1 6/1 TAG TTC - 1 2 6/2 TAG TTC - ta 3 6/3 TAG TTC - tag 4 6/4 (6/4') TAG TTC - taga 5 0/6 5' tag ttc 3' 6 0/9 5' tag ttc tag 3' 7 DNA oligo ladder FIG 10 Pπmer sequences on left side panels of Figure 9 in perfect match pπming of 38nt DNA template (SEQ ID NO 8) (upper case - PNA, lower case - DNA) FIG 1 1 Pπmer sequences on πght side panels of Figure 9 in mismatched pnmmg of 38nt DNA template (SEQ ID NO 12) with one-base mismatch at the 2nd base (c), complementary to the 2nd base after the PNA-DNA linkage, and 38nt DNA template (SEQ ID NO 13) with one-base mismatch at the 4th base (c), complementary to the 4th base after the PNA-DNA linkage in chimera pπmer 6/4' (upper case - PNA, lower case - DNA) FIG 12 MALDI-TOF mass spectroscopy of pnmer extension product, sample from lane 6, Figure 7 MW 8750 7 of fully extended PNA 6 DNA 23 product FIG 13 Polyacrylamide gel electrophoresis under denatuπng conditions (7M urea) and SYBR-Green staining Mouse Xist gene mRNA was reverse transcπbed with PNA-DNA chimera pπmer The cDNA copy was amplified with D2 and D3 pπmers to give 143bp and 210bp fragments FIG 14 Schematic of single nucleotide polymorphism (SNP) detection by one-base PNA-DNA chimera pπmer extension from wild type (WT) and mutant templates, and MALDI-TOF mass spectral analysis of extension products FIG 15 Polyacrylamide (15%) gel electrophoresis under denatuπng conditions with fluorescence detection (no staining) Detection of fluorescent labelled pπmer extension products by incorporation of TAMRA-dUTP with PNA- DNA chimera pπmer (SEQ ID NO 4) and 5' bιotm DNA 38nt template (SEQ ID NO. 8) V. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Reference will now be made in detail to the preferred embodiments of the invention While the invention will be descπbed in conjunction with the preferred embodiments, it will be understood that they are not intended to limit the invention to those embodiments On the contrary, the invention is intended to cover alternatives, modifications, and equivalents, which may be included withm the mvention as defined by the appended claims Generally, the present invention compπses pπmer extension methods where the pπmer is a PNA-DNA chimera The methods of the present invention find particular application in the area of nucleic acid analysis, e g DNA sequencing, fragment analysis, and detection of probe hybπdization in hybπdization assays V 1 DEFINITIONS Unless stated otherwise, the following terms and phrases as used herein are intended to have the following meanings "Nucleobase" refers to a nitrogen-containing heterocychc moiety, e g a puπne. a 7- deazapuπne, or a pynmidme Typical nucleobases are adenme, guanine, cytosine, uracil, thymine, 7-deazaademne, 7-deazaguanme, and the like "Nucleoside" refers to a compound consisting of a nucleobase linked to the C-l' carbon of a πbose sugar "Nucleotide" refers to a phosphate ester of a nucleoside. as a monomer unit or within a nucleic acid Nucleotides are sometimes denoted as "NTP", or "dNTP" and "ddNTP" to particularly point out the structural features of the πbose sugar "Nucleotide 5'- tπphosphate" refers to a nucleotide with a tπphosphate ester group at the 5' position. The tπphosphate ester group includes sulfur substitutions for the vaπous oxygens, e.g. α-thio- nucleotide 5 '-tπphosphates As used herein, the term "nucleic acid" encompasses the terms "o gonucleotide" and "polynucleotide" and means smgle-stranded and double-stranded polymers of nucleotide monomers, including 2'-deoxyπbonucleotιdes (DNA) and πbonucleotides (RNA) The nucleic acid may be composed entirely of deoxyπbonucleotides, entirely of πbonucleotides, or chimeπc mixtures thereof. The monomers are linked by mtemucleotide phosphodiester bond linkages, and associated counteπons, e.g., H + , NH + , tπalkylammonium, Mg + , and Na + Nucleic acids typically range in size from a few monomeπc units, e.g. 5-40 when they are commonly referred to as o gonucleotides, to several thousands of monomeπc units Whenever an ohgonucleotide sequence is represented, it will be understood that the nucleotides are in 5' to 3' order from left to πght and that "A" denotes deoxyadenosine, "C" denotes deoxycytidme, "G" denotes deoxyguanosine, and "T" denotes thymidme, unless otherwise noted The term "Watson/Cπck base-paiπng" refers to the hydrogen-bonding base paiπng commonly observed in double-stranded DNA "Attachment site" refers to a site on a moiety, e.g. a chimera or nucleotide, to which is covalently attached a linker "Linker" refers to one or more atoms used to space one moiety from another, e g. a label from a nucleotide 5 '-tπphosphate or the PNA moiety from a DNA moiety in a PNA- DNA chimera "PNA-DNA Chimera" refers to an oligomer, or ohgomers, compπsed of (1) a contiguous moiety of PNA monomer units and (n) a contiguous moiety of nucleotide monomer units with an enzymatically-extendable terminus "Alkyl" refers to a saturated or unsaturated, branched, straight-chain, branched, or cyclic hydrocarbon radical deπved by the removal of one hydrogen atom from a single carbon atom of a parent alkane, alkene, or alkyne. Typical alkyl groups include, but are not limited to, methyl, ethyl, propyl, butyl, and the like. In preferred embodiments, the alkyl groups consist of 1-12 saturated and or unsaturated carbons "Cycloalkyl" refers to a cyclic alkyl radical. Nitrogen atoms with cycloalkyl substituents may form aziridinyl, azetidmyl, pyrrolidinyl, pipeπdmyl, larger πngs, and substituted forms of heterocycles thereof. "Alkyldiyl" refers to a saturated or unsaturated, branched, straight chain or cyclic hydrocarbon radical of 1-20 carbon atoms, and having two monovalent radical centers deπved by the removal of one hydrogen atom from each of two different carbon atoms of a parent alkane, alkene or alkyne. Typical alkyldiyl radicals include, but are not limited to, 1,2-ethyldiyl, 1,3-propyldiyl, 1 ,4-butyldiyl, and the like. "Aryldiyl" refers to an unsaturated cyclic or polycychc hydrocarbon radical having a conjugated resonance electron system and at least two monovalent radical centers deπved by the removal of one hydrogen atom from each of two different carbon atoms of a parent aryl compound. Typical aryldiyl groups include, but are not limited to, radicals deπved from benzene, substituted benzene, naphthalene, anthracene, biphenyl, and the like. "Label" refers to any non-radioisotopic moiety covalently attached to a chimera or nucleotide that is detectable or imparts a desired functionality or property in the pπmer extension product (Hermanson, 1996) Prefeπed detectable labels are fluorescent dyes. "Primer extension" is the enzymatic addition, i.e. polymeπzation, of monomeπc nucleotide units to a pπmer while the pπmer is hybπdized (annealed) to a template nucleic acid. V.2 PNA-DNA CHIMERA PNA-DNA chimera are linear ohgomers compπsed of: 1) a contiguous moiety of PNA monomer units and 2) a contiguous moiety of nucleotides. The two moieties are covalently linked together The nucleotide moiety of the chimera may be 2'- deoxynucleotides, πbonucleotides. or a mixture thereof The nucleotide moiety of the chimera has a 3' hydroxyl terminus The preferred length of the PNA moiety is from 5 to 15 PNA monomer units, reflecting optimum enzymatic activity, hybπdization specificity and affinity, economy of synthesis reagents, and ease of chimera synthesis and puπfication The length of the DNA moiety is from 3 to 15 nucleotides The preferred length of the DNA moiety is the shortest sequence which promotes efficient pπmer extension, I e at least three 2'-deoxynucleotιdes (Figure ID) A preferred form of the PNA moiety is an uncharged backbone of N-(2- ammoethyl)-glycιne, a peptide-hke, amide-linked unit (Egholm, 1993, Nielsen, 1991) (Figure 1 A) Whenever a PNA sequence is represented as a seπes of letters, it is understood that the amino terminus is at the left side and the carboxyl terminus is at the πght side Binding of the PNA moiety to its DNA or RNA complement can occur in either a parallel or anti-parallel oπentation of PNA, however, the anti-parallel duplex (where the carboxyl terminus of PNA is aligned with the 5' terminus of DNA, and the ammo terminus of PNA is aligned with the 3' terminus of DNA) is typically more stable (Egholm, 1993). The chimera of the present invention are designed such that the PNA moiety anneals in the anti-parallel oπentation with the target sequences. Chimera sequences are typically completely complementary to a portion of the target sequence. However, chimera sequences may contain mixed-base ("redundant" or "degenerate") sites whereby a chimera sample may be a mixture of sequences with one or more sites represented by two or more different nucleobases. The mixed-base site may be located in the PNA or DNA moieties of the oligomer Mixed-base chimera are mixtures of sequences with varying levels of complementaπty to a particular target sequence Mixed-base chimera may be useful for random pπming or where template sequence information is unknown or uncertain. PNA-DNA chimera can be synthesized using the respective conventional methods of synthesis of PNA ohgomers, DNA ohgonucleotides, and RNA ohgonucleotides Chimera can be synthesized at a 2-25 μmole scale on commercially available, automated synthesizers, e g Expedite, Model 433A and Model 394 Synthesizers (PE Biosystems), and with commercially available reagents (Uhlmann, 1996, Vmayak, 1997, Van der Laan, 1997) In this approach, the chimera can be made continuously, in a single column and on a single synthesizer Synthesis of chimera is initiated by detπtylation of the 5' dimethoxytrityl (DMT) group of commercially available, high-cross link, non-swelling polystyrene beads packed in a synthesis column. The supports are loaded at 20-30 μmole/gm with 5' DMT deoxynucleosides (A bz , G lbu , C bz , T) linked through the 3' hydroxyl to the support through a base-labile succinate/hydroxymethylbenzoic acid linker (Vinayak, 1997). 5' DMT, 3' cyanoethyl phosphoramidite deoxynucleoside monomers (Beaucage, 1992) are dissolved in dry acetonitrile and delivered concurrently with tetrazole activator and coupled to the support-bound 5' hydroxyl. Coupling is followed by capping with acetic anhydride of unreacted 5' hydroxyls, and iodine oxidation to the pentavalent mtemucleotide phosphate triester. The DNA synthesis cycle is repeated until the last deoxynucleoside addition, where a 5' monomethoxytrityl (MMT) amino nucleoside phosphoramidite is employed to furnish a 5' amino terminus on the support-bound DNA moiety, for coupling to a PNA monomer at the linkage between DNA and PNA in the chimera. The MMT group is favored in the synthesis of PNA-DNA chimera because of its acid-lability. The MMT group is efficiently and rapidly removed under mild acidic conditions which do not cause depurination or other damage to the chimera. To initiate synthesis of the PNA moiety, the 5' MMT group is removed with 3% trichloroacetic acid in dichloromethane and the amino group is coupled with a PNA monomer and a coupling reagent. The backbone amino group of the PNA monomers is preferably protected with MMT and the nucleobase exocyclic amines are protected as A bz , G ibu , and C bz (Breipohl, 1997; Finn, 1996; Will, 1995) Any conventional peptide coupling reagent may be used, but HBTU and HATU are preferred coupling reagents. PNA monomers may be dissolved in 1 :1 DMF:acetonitrile to a concentration of about 0.2M. Prior to delivery to the synthesis column, the monomer solution was mixed with an equal volume of 0.2M HBTU (O-benzotriazol-1 -yl-N,N,N',N'-tetramethyluronium hexafluorophosphate), also in 1 :1 DMF: acetonitrile (Vinayak, 1997). The solution was delivered to the column concurrently with 0.2M diisopropylethylamine in 1 : 1 DMF:acetonitrile. The synthesis cycles for the PNA and DNA moieties in a chimera are summarized in Table 1 below. PNA DNA Model 394 synthesizer, 2 μmole scale. After synthesis is complete, the amino terminus may be acetylated to minimize migration or cyclization, or reacted as a nucleophile in labelling. The cmde chimera is cleaved from the support, and all protecting groups are removed with concentrated ammonium hydroxide at 55 °C for 8-16 hours. The chimera are analyzed and purified by reverse-phase HPLC or polyacrylamide gel electrophoresis (PAGE), analyzed by mass spectroscopy, and quantitated by correlating UV absorbance at 260 nm with mass. Chimera with a DNA moiety comprising ribonucleotides can be synthesized with the appropriate RNA phosphoramidite nucleosides and/or 5' DMT protected ribonucleotides support (Vinayak, 1994). The 2' hydroxyl of RNA phosphoramidites are typically protected with the tert-butyldimeffiylsilyl (TBDMS) group and the exocyclic amino groups of the nucleobases are protected as A bz , G dmf , C bz . After synthesis, TBDMS groups are removed with a fluoride reagent, e.g. tetrabutylammonium fluoride in tetrahydrofuran. Otherwise, the synthesis, purification, and analysis methods for ribonucleotide-containing PNA-DNA chimera are virtually the same as for chimera with only 2'-deoxynucleotide containing DNA moieties. The PNA and DNA moieties are covalently linked together. The linkage may be a direct bond, e.g. an amide bond formed by the amino group at the 5' of a deoxynucleotide and the carboxyl group at the carboxyl terminal of the PNA moiety. The linkage may also comprise one or more units of a non-base pairing moiety such ethyleneoxy, linked to the PNA and DNA moieties by amide or phosphate bonds. Ethyleneoxy linkage units between the PNA and DNA moieties can be installed by coupling reagents such as protected forms of 2-[2-(2-amιnoethoxy)ethoxy]acetιc acid. The O-hnker, 2-[2-(2- aminoethoxyjacetic acid, is coupled as the MMT-amino protected amide-forming carboxyhc acid, or phosphoramidite synthons (Figure 5). One or more O linker units act as a flexible, non-base paiπng, linkage between the PNA and DNA moieties. Figure 6 shows a bis-ethyleneoxy-acetamido linker (6A) and a bis-ethyleneoxy-phosphate linker (6B) Other linkers include alkydiyl, e g hexyldiyl (Vinayak, 1997), or 1 ,4-phenyldιyl (Figure 5). V.3 NUCLEOTIDE 5'-TRIPHOSPHATES Nucleotide 5 '-tπphosphates are substrates of polymerase enzymes and are incorporated into the template/chimera hybπd by mtemucleotide phosphodiester bond formation between the 3' hydroxyl terminus of the chimera and the 5' hydroxyl of the nucleotide. Further extension by incorporation of more nucleotide 5 '-tπphosphates requires a new 3' hydroxyl terminus. Dunng pπmer extension, typically a mixture of nucleotide 5 '-tπphosphates are present, e.g. dATP, dGTP, dCTP and dTTP. Labelled nucleotides may also be present, for detection, isolation, or immobilization of the extension fragments. Nucleotides which terminate extendability ("terminators" or "terminating nucleotides") may also be present in the mixture, e.g. ddNTP and 2',3'- dehydro-ddNTP Labelled terminators are particularly useful. Individual concentrations of each nucleotide in the mixture are optimized to promote the desired incorporation rates and achieve the necessary detection levels. Preferred nucleotide 5'-triphosphates of the present invention are shown below m the general structures: 2',3'-dehydro-ddNTP where B is a nucleobase The 2' position of the πbose sugar moiety may be substituted with 2'-0-alkyl, e g methyl, 2'-amιno or 2'-halo, e g fluoro, chloro, as in the structure where X is alkoxy, halo, and ammo When B is a puπne or a 7-deazapunne, the sugar moiety is attached at the N 9 -posιtιon of the puπne or deazapuπne, and when B is a pyπmidme, the sugar moiety is attached at the N'-position of the pyπmidme Preferably the nucleotide 5 '-tπphosphate is ATP, dATP, ddATP, CTP, dCTP, ddCTP, GTP, dGTP, ddGTP, UTP, dUTP, TTP, dTTP, ddTTP, 5-methyl-CTP, 5-methyl- dCTP, ITP, dlTP, ddlTP, 2-ammo-ATP, 2-amιno-dATP, 7-deaza dATP, 7-deaza ddATP, 5-propynyl dCTP, 7-deaza dGTP, 7-deaza ddGTP, 5-Br-UTP, 5-Br-dUTP, 5-F-UTP, 5-F- dUTP, 5-propynyl-dUTP Additionally, the α-phosphoms may be substituted with sulfur, as the α-thio-nucleotide 5 '-tπphosphates (Lee, 1992) V 4 POLYMERASE ENZYMES A vaπety of polymerases, e g Vent (Kong, 1993), Klenow, Bst, bacteπophage T7 DNA polymerase (Tabor, 1989) and its processivity-enhancmg protein partner, E. coh thioredoxm, bacteπophage T4 DNA polymerase and its processivity clamp, gp45 protein (Carver, 1997), Taq, and Sequenase conduct pπmer extension of PNA-DNA chimera Preferred polymerases include Vent, Klenow and Bst Polymerases without exo activity (Exo ) proofreading function are preferred. Reverse transcπptase enzymes extend PNA-DNA chimera from RNA templates to make cDNA copies with nucleotide 5 '-tπphosphates Preferred reverse transcπptases are from avian myeloblastosis vims (AMV) and muπne leukemia vims (MuLV) and HIV V 5 NUCLEOTIDES Preferred nucleobases in one or more nucleosides include, but are not limited to, adenine, guamne, cytosme, uracil, thymine, 7-deazaademne, 7-deazaguanme, C-5-alkyl pyπmidmes, 2-thιopyπmιdme, 2,6-dιammopuπne. C-5-propyne pyπmidme, phenoxazme (Flanagan, 1999), 7-deazapuπne, lsocytidme, pseudo-isocytidme (Egholm, 1995), isoguanosme, 4(3 H)-pyπmιdone, hypoxanthine, and 8-oxopuπnes (Meyer, 1994) Prefeπed sugars in one or more of the nucleosides include, but are not limited to, 2'-deoxyribose, ribose, and 2'- or 3'-ribose modifications where the 2'- or 3'-position may be hydrogen, hydroxy, methoxy, ethoxy, allyloxy, isopropoxy, butoxy, isobutoxy, methoxyethyl, alkoxy, phenoxy, azido, amino, alkylamino, fluoro. chloro and bromo. Other preferred sugars include 4'-α-anomeric nucleotides, l '-α-anomeric nucleotides, and 2'-4'-linked and other "locked", bicyclic sugar modifications (Wengel, 1999). V.6 LABELS The PNA-DNA chimera or the nucleotide 5'-triphosphates may bear covalently attached non-radioisotopic labels. The chimera and one or more of the nucleotide 5'- triphosphates in a primer extension reaction may bear the same or different labels. Labeling can be accomplished using any one of a large number of known techniques employing known labels, linkages, linking groups, reagents, reaction conditions, and analysis and purification methods. Generally, the linkage linking the dye and nucleotide or chimera should not (i) interfere with primer extension, (ii) inhibit polymerase activity, or (iii) adversely affect the fluorescence properties of the dye, e.g. quenching or bleaching. PNA-DNA chimera and nucleotide 5'-triphosphates can be labelled at sites including a nucleobase, a sugar, the aminoethylglycine backbone, amino, sulfide, hydroxyl, and carboxyl. Nucleobase label sites include the N-9 or C-8 positions of the purine or deazapurine, and the C-5 position of the pyrimidine. Preferably, the linkage between the label and the chimera or nucleotide 5'-triphosphate are acetylenic amido or alkenic amido linkages (Khan, 1998). Linkers can also comprise alkyldiyl, aryldiyl, or one or more ethyleneoxy units (Rajur, 1997). Typically, a carboxyl group on the label is activated by forming an active ester, e.g. N-hydroxysuccinimide (NHS) ester and reacted with an amino group on the alkynylamino- or alkenylamino-derivatized chimera or nucleotide. Labelled 2',3'-dideoxynucleotides, ddNTP, find particular application as chain terminating agents, or "terminators" in the Sanger-type DNA sequencing method of primer extension, and for sizing/identification and analysis. Labelled deoxynucleotides, dNTP, find particular application as means for labelling primer extension products, e.g. in the polymerase chain reaction (Mullis, 1987). A preferred class of labels provide a signal for detection of labelled extension products by fluorescence, chemiluminescence, and electrochemical luminescence (Kπcka. 1992) Particularly preferred chemiluminescent labels are 1.2-dιoxetane compounds (Bronstein, 1994, Bronstein, 1990) Fluorescent dyes useful for labelling chimera and nucleotide 5 '-tπphosphates include fluoresceins (Menchen, 1993), rhodamines (Bergot, 1994), cyanines (Lee, 1998 (Ser No 09/012,525), Kubista, 1997), and metal porphyπn complexes (Stanton, 1988) Examples of fluorescein dyes include 6-carboxyfluoresceιn (6-FAM), 2',4',1,4,- tetrachlorofluorescein (TET), 2',4',5',7',1,4-hexachlorofluoresceιn (HEX), 2',7'- dιmethoxy-4',5'-dιchloro-6-carboxyrhodamme (JOE), 2'-chloro-5'-fluoro-7',8'-fused phenyl- 1 ,4-dιchloro-6-carboxyfluoresceιn (NED), 2'-chloro-7'-phenyl-l,4-dιchloro-6- carboxyfluorescem (VIC), and (JODA) (Figures 3A-3B) The 5-carboxyl, and other regio-isomers, may also have useful detection properties Fluorescein and rhodamine dyes with 1 ,4-dιchloro substituents (bottom πng as shown) are especially preferred Another preferred class of labels include fluorescence quenchers The emission spectra of a quencher overlaps with a proximal intramolecular or mtermolecular fluorescent dye such that the fluorescence of the fluorescent dye is substantially diminished, or quenched, by the phenomena of fluorescence resonance energy transfer "FRET" (Clegg, 1992) Particularly preferred quenchers include but are not limited to (l) rhodamine fluorescent dyes selected from the group consisting of tetramethyl-6-carboxyrhodamιne (TAMRA), tetrapropano-6-carboxyrhodamme (ROX), and (n) DABSYL, DABCYL, cyanme dyes including mtrothiazole blue (NTB), anthraqumone, malachite green, mtrothιazole,and mtroimidazole compounds and the like (Figure 4) Nitro-substituted forms of quenchers are especially preferred Energy-transfer dyes are a preferred class of ohgonucleotide labels An energy- transfer dye label includes a donor dye linked to an acceptor dye (Lee, 1998, U S Patent 5,800,996), or an intramolecular FRET pair (Livak, 1998, Livak, 1996, Tyagi, 1996) Light, e g from a laser, at a first wavelength is absorbed by a donor dye, e g FAM The donor dye emits excitation energy absorbed by the acceptor dye The acceptor dye fluoresces at a second wavelength, with an emission maximum preferably about 100 nm greater than the absorbance maximum of the donor dye The donor dye and acceptor dye of an energy-transfer label may be directly attached by a linkage such as O II — CH 2 NHC — formed from an aminomethyl group at the 4' or 5' positions of the donor dye, e.g. FAM. and a 5- or 6-carboxyl group of the acceptor dye (Figure 3B). Other rigid and non-rigid linkers may be useful. Another preferred class of labels serve to effect the separation or immobilization of labelled primer extension products by specific or non-specific capture means, e.g. biotin, 2. 4-dinitrophenyl (DNP), and digoxigenin (Andrus, 1995). Another prefeπed class of labels are electrophoretic mobility modifiers, e.g. polyethyleneoxy (PEO) units. The PEO label may be comprised of charged groups, such as phosphodiester to impart charge and increase electrophoretic mobility (velocity). The PEO label may be uncharged and act to retard electrophoretic mobility. Such modifiers may serve to influence or normalize the electrophoretic velocity of a set of labelled primer extension products during analysis, e.g. by fluorescent detection, to improve resolution and separation (Grossman, 1995) Another preferred class of labels, referred to herein as hybridization-stabilizers, include but are not limited to minor groove binders, intercalators, polycations, such as poly-lysine and spermine, and cross-linking functional groups. Hybridization-stabilizers may increase the stability of base-pairing, i.e. affinity, or the rate of hybridization (Corey, 1995) of the chimera and the template. Hybridization-stabilizers serve to increase the specificity of base-pairing, exemplified by large differences in Tm between perfectly complementary ohgonucleotide and target sequences and where the resulting duplex contains one or more mismatches of Watson/Crick base-pairing (Blackburn, 1996, pp. 15- 81 and 337-46). Preferred minor groove binders include Hoechst 33258 (Rajur, 1997), CDPIi , 3 (Kutyavin, 1996), MGB1 (Gong, 1997), V.7 PRIMER EXTENSION Primer extension is initiated at the template site where a primer anneals. One or more different nucleotide 5'-triphosphates may be present in the reaction mixture such that the complementary nucleotide is incorporated by a polymerase enzyme according the template sequence. Extension of the chimera continues until nucleotides are depleted, the enzyme is no longer functional, or termination occurs by incorporation of a terminating nucleotide that will not support continued DNA elongation. Chain-terminating nucleotides are typically 2',3'-dιdeoxynucleotιde 5 '-tπphosphates (ddNTP), which lack the 3'-OH group necessary for 3' to 5' DNA chain elongation Other terminating nucleotides include 2',3'- dideoxy-dehydro, 2'-acetyl, 2'-deoxy, halo, and other 2'-substιtuted nucleotide 5'- tπphosphates In general, the reaction conditions for pπmer extension involve an appropπate buffeπng system to maintain a constant pH, a divalent cation, a PNA-DNA chimera pπmer, a template nucleic acid, nucleotide 5 '-tπphosphates, and a polymerase Additional pπmer extension reagents, such as reducing agents, monovalent cations, or detergents may be added to enhance the reaction rate, fidelity, or other parameters Different polymerases may have different optimal pH values or ion concentrations Klenow without exo activity (exo-) extended PNA-DNA chimera pπmers compπsed of six contiguous PNA monomers and three or four contiguous 2'- deoxynucleotides (Figures 7 and 8) The same chimera were not extended to give full length product by AmphTaq FS ® polymerase (Figure 7 middle panel). PNA-DNA chimera with 0-2 2'-deoxynucleotιdes were not extended by either enzyme (Figures 7 and 8). The identity of the full length 29 nt (PNA <3 DNA 23 ) extension product from lane 6 in Figure 7 was confirmed by MALDI-TOF mass spectroscopy (Figure 12). The specificity advantage of PNA-DNA chimera pπmers relative to DNA pπmers is shown in Figure 9 When vaπous pπmers were extended with Klenow (exo-) or Bst polymerases on a 38nt DNA template (SEQ. ID NO. 8) with perfect complementaπty (Figure 10), chimera pπmers with three (6/3) and four (6/4) 2'-deoxynucleotιdes were extended, as well as the corresponding all-DNA 9nt pπmer (0/9) The all-DNA hexamer (0/6) showed a weaker band under the SYBR-Green staining detection The all-DNA extension products from 0/6 and 0/9 pπmers migrated faster than the PNA-DNA extension products from 6/3 and 6/4 However, when the template contained a mismatch either across from the 2nd base (SEQ. ED NO. 12) or 4th base (SEQ. ID NO. 13) from the PNA-DNA linkage site, the PNA-DNA chimera did not extend (Figure 11) The all-DNA 9nt pπmer (0/9) did extend, showing a band of near equal intensity to the perfect match extension product. Thus while the all-DNA pπmer showed little specificity, i.e. sequence discπmination of a mismatch, the corresponding PNA-DNA chimera showed absolute specificity withm the detection limits of the expeπment The results of this expeπment follows other reports that PNA probes are more sensitive to mismatches than DNA probes (Kyger, 1998) Labeled pπmer extension products, "fragments", are generated through template- directed enzymatic synthesis using labeled chimera pπmers or nucleotides The fragments can be separated by a size-dependent process, e g , electrophoresis or chromatography, and the separated fragments detected, e g , by laser-induced fluorescence In a preferred fragment analysis method, Sanger-type sequencing, a chimera pπmer is extended by a DNA polymerase in vitro using a smgle-stranded or double-stranded DNA template whose sequence is to be determined Extension is initiated at a defined site based on where a chimera anneals to the template The extension reaction is terminated by incorporation of a nucleotide that will not support continued DNA elongation, 1 e a terminating nucleotide When optimized concentrations of dNTP and terminating nucleotides are used, enzyme- catalyzed polymeπzation (extension) will be terminated m a fraction of the population of chains at each site where the terminating nucleotide is incorporated such that a nested set of pπmer extension fragments result If fluorescent dye-labeled chimera pπmers or labeled terminating nucleotides are used for each reaction, the sequence information can be detected by fluorescence after separation by high-resolution electrophoresis (Smith, 1998) Each of the four possible terminating nucleotides (A,G,C,T) may be present in the extension reaction and bear a different fluorescent dye which are spectrally resolvable (Bergot, 1994) "Mim-sequencmg" is another application involving incorporation of terminating nucleotides m single-base extension assays where PNA-DNA chimera may be useful to determine the identity, presence, or absence of a nucleotide base at a specific position in a nucleic acid target of interest (Goelet, 1999, Syvanen, 1990) Genotype determination based on identification of different alleles is based on single nucleotide polymorphisms (SNP) SNP can be detected by ddNTP incorporation from PNA-DNA chimera pπmers annealed immediately adjacent to the 3' of the SNP site of the target nucleic acid sequence to be determined, and detection of the extension products by MALDI-TOF mass spectroscopy (Figure 14) The mass difference resulting from incorporation of different dideoxynucleotides can be accurately determined by mass spectrometry More than one chimera pπmer, each with a different sequence and mass, allows detection of multiple SNP in a single tube or reaction, by analyzing the mass spectra of the extension products Pπmed in situ labeling (PRINS) is a molecular cytogenetic technique that combines the high sensitivity of PCR with the cellular or chromosome localization of fluorescent signals provided by in situ hybπdization PRINS can be conducted by annealing unlabelled PNA-DNA chimera pπmers to complementary target sequences, followed by a DNA polymerase extension in the presence of labelled dNTP Preferably the labels are fluorescent dyes, so that the extension products can be detected and/or measured by fluorescence detection (Koch, 1991 ) In one embodiment of the invention, the PNA-DNA chimera is immobilized to a solid substrate through an ionic attraction, affinity/receptor interaction, or covalent linkage The solid substrate may be particles, beads, membranes, frits, slides, plates, micromachined chips, alkanethiol-gold layers, non-porous surfaces, or other polynucleotide-immobihzing media The solid substrate mateπal may be polystyrene, controlled-pore-glass, silica gel, silica, polyacrylamide, magnetic beads, polyacrylate, hydroxyethylmethacrylate, polyamide, polyethylene, polyethyleneoxy, and copolymers and grafts of such In this embodiment, the chimera may be physically manipulated by automated means, e g. assembling an addressable array of multiple chimera, pπor to pπmer-extension Pπmer extension reagents, including template, nucleotide 5 '-tπphosphates, and polymerase may be delivered m solution to the location, well, vessel, or spot of the solid substrate beaπng the chimera. Pπmer extension may be conducted m such a heterogeneous media After extension is complete, all reagents in solution may be conveniently removed by filtration, aspiration, centπfugation, sedimentation, decanting, or magnetic pull-out of magnetic particles. Alternatively, pπmer extension products may be detached or released from the solid substrates in a pure state by selective chemical, thermal, or enzymatic cleavage In another and similar embodiment, a template nucleic acid may be immobilized on a solid substrate in the same configurations and mateπals (supra) Pπmer extension reagents including PNA-DNA chimera, nucleotide 5 '-tπphosphates, and polymerase may be delivered in solution to the unmobilized template and pπmer extension conducted m a heterogeneous media Pπmer extension products can be conveniently separate from the template and detected. VI. EXAMPLES The invention will be further claπfied by a consideration of the following examples, which are intended to be purely exemplary of the present invention and not to limit its scope in any way. Example 1 Labelling of PNA-DNA chimera TAMRA and NTB labeling: Labeling is performed with 5 mg of NHS ester of TAMRA or NTB dissolved in 100 μl DMF or NMP and 10 μl DIEA added to the support bound PNA-DNA chimera and allowed to react for 2 to 18 hours (typically overnight). The support is washed following the labeling with DMF and subsequently DCM pπor to cleavage. CDPI labeling CDP is attached to the chimera by three consecutive couplings of Fmoc-CDPI (Lukhtanov, 1995) to give CDPI 3 -labelled PNA-DNA chimera. The CDPI monomer unit, l ,2-dιhydro-(3H)-pyrrolo[3,2-e]ιndole-7-carboxylate, protected with Fmoc (5 mg, 0.012 mmole) is dissolved in 100 μl NMP and activated by 0.95 equivalents HATU (0.2M in DMF) and 2 equivalents DIEA (0.4M in DMF). After one hour at room temperature, the activated Fmoc-CDPI solution is added to the support bound chimera and allowed to couple for another hour at room temperature. The resin is washed following the coupling with 20 ml DMF. The Fmoc is removed by treatment of the resin support with 1 :4 pιperidine:DMF for 10 minutes at room temperature. This coupling and deprotection cycle is repeated two additional times for a total of 3 manual couplings to give CDPI 3 - labelled PNA-DNA chimera. Example 2 primer extension from DNA 38mer template with Klenow, Taq FS, and no enzyme control AC-TAG TTC - 1 (SEQ. JJD NO. 2) Ac-TAG TTC - ta (SEQ. ID NO. 3) Ac-TAG TTC - tag (SEQ. ID NO. 4) Ac-TAG TTC - taga (SEQ. ID NO. 5) Ac-TAG TTC T - ag (SEQ. ID NO. 9) Ac-TAG TTC T - aga (SEQ. ID NO. 10) Ac-TAG TTC T - agac (SEQ. ID NO. 1 1 ) UPPER CASE = PNA, lower case = DNA. All chimera above have amide linkage. Amino terminus of PNA is acetylated (Ac). 2.1 Annealing of pπmers and templates PNA-DNA chimera, PNA, and DNA pπmers (Figures 7-1 1 ) were annealed to the synthetic 38-mer DNA ohgonucleotide templates 5' CGC TCA ACA CAT AGC ATG GTC TAG AAC TAA GCC TGG AA 3' (SEQ ID NO 8) 5' CGC TCA ACA CAT AGC ATG GTC CAG AAC TAA GCC TGG AA 3' (SEQ ID NO 12) 5' CGC TCA ACA CAT AGC ATG GCC TAG AAC TAA GCC TGG AA 3' (SEQ ID NO 13) where bold, underlined bases indicate mismatch bases The mixtures were heated to 95 °C and slowly cooled to 37°C dunng one hour in a fhermocycler instrument (PE GeneAmp PCR System 9700, PE Biosystems) 2.2 Polymerase extension reaction with non-thermostable DNA polymerases PNA-DNA chimera and DNA pπmers were extended from their respective 3'-OH ends for 2 to 16 h at 37°C with 2 5-50 units of DNA polymerase, e.g. Klenow, T4, or Bst DNA polymerase, and pπmer-extension buffer in 25 to 100 μl total volume In the case of Klenow, for example, 0.1 to 1 mM each nucleotιde-5'-tπphosphate and lx EcoPol buffer contaimng 10 mM Tπs-HCl (pH 7.5), 5 mM MgCl 2 , and 7.5 mM dithiothreitol were added into each reaction. 2.3. Pnmer extension reaction with thermostable DNA polymerases A total of 50 μl of pπmer extension mixture generally includes 2.5 to 25 U thermostable polymerase (I e AmpliTaq Gold), lx PCR buffer II containing 50 mM KC1, 10 mM Tπs-HCl, pH 8 3, 200 to 500 μM of each dNTP, and 2 to 4 mM of MgCl 2 . Pnmer extension is performed for 25-40 rounds of thermal cycling in a program (10 min at 95 °C once, then 0 5 mm at 95 °C, 1 to 5 mm at 37 to 67 °C, 1 to 10 mm at 60 to 72 °C for cycling). 2.4. Electrophoresis and visualization After incubation, reaction product was placed on ice or at 4°C for a short peπod. Typically, 5 to 25 pmol of the extended product was mixed with a final concentration of lx loading buffer (45 mM Tπs base, 45 mM bone acid, 0.4 mM EDTA, 3% Ficoll, 0.02% bromophenol blue, 0.02% xylene cyanol) and denatured at 95 °C for 10 to 20 mm. The sample is loaded into a 10 to 15% denatunng PAGE gel and mn in lx TBE (89 mM Tπs base, 89 mM bone acid, 2 mM EDTA, pH 8 3) at 100 to 160 V, 70 °C for 25 to 60 mm. The extended product was visualized by staining the gel with SYBR-Green (Molecular Probes. Eugene, OR) in a volume of 40 to 120 ml in lχ TBE for 10 to 30 min. The image was captured in an Chemlmaging 2000 gel documentation system. In the case of Klenow polymerase. for example, reaction conditions are 25 °C and 10 mM Tris-HCl pH 7.5, 5 mM MgCl 2 , 7.5 mM dithiothreitol, 1 mM each nucleotide 5'- triphosphate, 0.1 to 100 pmoles chimera, 0.1 to 100 pmoles template, and 0.1 to 10 units Klenow enzyme in 5 to 500 μl total volume. A Taq polymerase primer extension reaction may be conducted at 72-80 °C and contain 10 mM KC1, 20 mM Tris-HCl pH 8.8, 10 mM (NH 4 ) 2 SO 4 , 2 mM MgSO 4 , 0.1% Triton X-100 detergent, 1 mM each nucleotide 5 '-triphosphate, 0.1 to 100 pmoles chimera, 0.1 to 100 pmoles template, and 0.1 to 10 units Taq polymerase enzyme in 5 to 500 μl total volume. 2.5. MALDI-TOF analysis Mass spectra is acquired on a MALDI-TOF MS (Voyager DE) workstation. Desalted samples are mixed 1 :1 with matrix solution consisting of 50 mg/ml 3-hydroxy picolinic acid, 50 mM ammonium citrate, and 30% acetonitrile, and is spotted onto a sample plate. Time-of-flight data from 20 to 50 individual laser pulses are recorded and averaged on a transient digitizer, after which the averaged spectra are automatically converted to mass by data processing software. Example 3 RT-PCR murine Xist gene PI Ac- TA GGT CCC GGC ttta (SEQ. ID NO. 14) P2 Ac- TA GGT CCC GGC t (SEQ. ID NO. 15) DI AAC AGT TA GGT CCC GGC TTT (SEQ. ID NO. 16) D2 ACT GGG ATG CAA AGA GCA TT (SEQ. ID NO. 17) D3 TGC CTG GGA TAA AAG CAA AG (SEQ. ID NO. 18) Total RNA was isolated by using the guanidinium thiocyanate method from kidneys of male and female mice (Chirgwin, 1979). Reverse transcription was conducted on 0.5 to 1.5 μg total RNA samples with 10 pmoles of Xist-specific primers including DNA RT primer DI or PNA-DNA chimera RT primers PI and P2, respectively, 0.2-1 mM each of dATP, dGTP, dCTP, dTTP, 10 to 20 μl RT reaction buffer ( 10 mM Tris- HCl, pH 8.3, 90 mM KC1), and 2 to 10 U recombinant Thermus thermophilus (τTth) DNA polymerase. The solution was incubated for 10 min at 65 °C followed by 60 min at 60 °C. The samples were PCR amplified (30s at 94°C, 30s at 55°C, and 30s at 65°C) in IX chelating buffer [5% (v/v) glycerol, 10 mM Tris-HCl, pH 8.3. 0.05% Tween 20, 0.75 mM EDTA] with 2 to 10 U τTtlι DNA polymerase and 20 pmoles of each primer (D2 and D3). PCR products were separated and analyzed by 1 to 3% agarose gel electrophoresis with SYBR-Green staining (Figure 13). The P2 PNA-DNA chimera, with four 2'- deoxynucleotides, was effective in producing an amplifiable copy of mouse Xist gene, whereas the PI chimera, with only one 2'-deoxynucleotide, was not. In the case of M-MuLV reverse transcriptase, altered reaction conditions were 37 °C and 50 mM Tris-HCl pH 8.3, 8 mM MgCl 2 , 10 mM dithiothreitol, 1 mM each dNTP, 0.1 to 100 pmoles chimera primer, 0.1 to 100 pmoles template, and 0.1 to 10 U M-MuLV enzyme in 5 to 500 μl total volume. Example 4 SNP detection A nested PCR is generally recommended for genomic targets. Briefly, 5 pmoles PCR primers flanking the target sequences are subject to 10 rounds of thermal cycling (30s at 94 °C, 30s at 55-70 °C) in 25 μl of reaction buffer comprising 1 x Taq buffer described previously, 400 μM of each dNTP, 4 mM MgCl , 20-50 ng human genomic DNA, 0.5 to 5 U Taq DNA polymerase or other thermostable enzymes. After 50 pmoles specific pairs of DNA primers are added, the mixture is thermal cycled for an additional 15 -20 rounds to amplify all loci. Multiplex SNP extension assay To 20 μl PCR mixture is added 1 U each of shrimp alkaline phosphatase and 10 U exonuclease I. The mixture is incubated for 15 min at 37 °C followed by 15 min at 85 °C. Then, 20 μl of a mixture containing 25-100 μM each ddNTP, 2 mM MgCl 2 , 1 to 5 U Taq polymerase, IX PCR buffer, and 20-50 pmoles of each PNA-DNA chimera primer is added subsequently. The resultant mixture is subjected to 25-35 rounds of thermal cycling (30s at 94 °C, 30s at 37 to 67 °C, 20-90s at 70 °C). Desalting 10 to 50 μl of the reaction mixture is performed by absorption/elution using ZipTip or 96-well plate packed with small quantities of POROS 50 Rl, R2, or R3 chromatography media. Example 5 Fluorescence detection of primer extension of PNA-DNA chimera with TAMRA-dUTP PNA-DNA chimera primer (SEQ. ID NO. 4) was extended with 3 different mixtures of nucleotides (a., b., c.) after annealing to 5' biotin DNA 38nt template (SEQ. ID NO. 8) with a variety of polymerases (Figure 15). The biotin label serves to enable capture affinity of duplex extension products or recovery of template by binding to avidin, e.g. immobilized strepavidin. Polyacrylamide (15%) gel electrophoresis under denatuπng conditions with fluorescence detection (no staining) showed only the expected fluorescence in reactions (b) with TAMRA-dUTP. The dark bands at 15 and 20 bp correspond to TAMRA-dUTP and a dimer artifact, respectively. Full length extension product is apparent in reactions employing (left to right) Klenow, AmpliTaq, TaqGold, Vent, Stoffel fragment, and Sequenase as a faint band migrating at the rate of a 30 bp DNA duplex. These results demonstrate the incorporation of a labelled nucleotide, e.g. TAMRA-dUTP, with a range of polymerases. Example 6 Primed in situ labeling (PRINS) - Chromosome labelling by PNA-DNA chimera primer extension with TAMRA-dUTP A reaction mixture containing 1 - 3 μM PNA-DNA chimera primer, 100 to 200 μM of each dATP, dCTP, dGTP, 20 μM dTTP, 20 μM of FAM-12-dUTP, 50 mM KC1, 10 mM Tris-HCl, pH 8.3, 1-5 mM MgCl 2 , 0.01% bovine semm albumin, and 2 to 10 U Taq DNA polymerase is prepared to a final volume of 50 μl. A total of 20 to 30 μl reaction mixture is placed on each slide. The slide is incubated on a programmable temperature cycler (PE Ampli2000). The program consists of 15-30 min at 50-65 °C for annealing and 30 to 120 min at 72 °C for extension. The reaction is stopped by immersing the slides in 50 mM NaCl, 50 mM EDTA, pH 8 at 72 °C for 5 min. After incubation, the slides are washed three times with 70% formamide/10 mM Tris pH 7.2 for 10 min and with 0.05 M Tris/0.15 M NaCl 0.05% Tween-20 pH 7.5 for 5 min. The slides are then dehydrated in an ethanol series and air dried in the dark. Chromosomes are counterstained with either 0.1 μg/ml of 4,6-diamidino-2-phenylindole-dehydrochloride (DAP I) in antifade or 0.6 μg/ml of propidium iodide (Oncor, Gaitherburg, MD). Example 7 DNA sequencing with PNA-DNA chimera primer and fluorescent dye- labelled terminating nucleotide 5'-triphosphates Rhodamine labelled, 2',3'-dideoxynucleotides and PNA-DNA chimera primer: Ac-ACG ACG GCC agt 3' (SEQ ID NO 19) are used to label DNA fragments in chain termination sequencing on an Applied Biosystems 10 Genetic Analyzer The template nucleic acid, pGEM, (0 4 pmoles) was annealed with the pnmer (0 8 pmoles) and pnmer-extension reagents compnsing 2 μl buffer (400 mM Tπs-HCl, 10 mM MgCl 2 , pH 9 0 ), 2 μl of a deoxynucleotide / labelled dideoxynucleotide mixture, and 2 μl of AmpliTaq DNA polymerase FS enzyme (5 Umts/μl) The FS enzyme is a recombinant Thermus aquaticus DNA polymerase having two point mutatιons-G46D and F667Y The protocol is provided in the ABI PRISM™ Dye Terminator Cycle Sequencing Core Kit Manual (PE Biosystems) The reaction is then thermocycled using the following exemplary program, denaturation at 98 °C for 5 s followed by repeated cycles of 96 °C for 5 s, 55 °C for 40 s, and 68 °C for 1 mm This cycle is repeated approximately 15 times The nucleotide mixture consists of dNTP: 2 mM each dATP, dCTP, 7-deaza- dGTP and dTTP, and labelled ddNTP- 9 0 μM 5R6G-ddATP, 2.7 μM 5R110-ddGTP, 54 μM 6ROX-ddCTP, and 216 μM 6TMR-ddTTP. The pπmer extension sequencing reactions can be conducted in 0.5 ml tubes adapted for a thermal cycling reaction peπod m a thermal cycler, e.g. Perkm-Elmer 480 DNA Thermal Cycler (PE Biosystems) Reaction volumes may be 20 μl, including 15 μl of the above reaction premix, a vaπable amount of fluorescent dye-labeled terminator, and a sufficient volume of water to bnng the total reaction volume up to 20 μL. From 1 to 1000 pmol of the dye terminator can be added to each reaction. Mineral oil (30 μl) is added to the top of each reaction to prevent evaporation Reactions are thermocycled as follows: 96 °C for 30 sec, 50 °C for 15 sec, and 60 °C for 4 mm, for 25 cycles; followed by a 4 °C hold cycle. Reactions are puπfied on Centn-Sep spin columns according to manufacturer's instructions (Pπnceton Separations) After the column is hydrated with 0.8 mL deionized water for at least 30 minutes at room temperature, inspected to determine that no bubbles are trapped in the gel matenal, the upper and lower end caps of the column are removed, and the column is allowed to drain by gravity. The column is then inserted into the wash tubes provided in the kit and centnfuged in a vanable speed microcentnfuge at 13,000 x g for 2 minutes, removed from the wash tube, and inserted into a sample collection tube The reaction mixture is carefully removed from under the oil and loaded onto the gel mateπal Loaded columns are centnfuged to elute the samples which are then dπed in a vacuum centπfuge Pπor to loading onto a sequencing gel, the dπed samples are resuspended in 25 μl of Template Suppression Reagent (PE Biosystems), vortexed, heated to 95 °C for 2 minutes, cooled on ice. vortexed again, and centnfuged. A 10 μl aliquot of the resuspended sample is transferred to sample vials for electrophoresis on the PE ABI PRISM™ 310 Genetic Analyzer (PE Biosystems) with sieving polymers including nucleic acid denaturants, and capillanes specially adapted for DNA sequence analysis. Samples are electrokinetically injected onto the capillary for 30 s at 2.5 kV, and mn for 2 hr at 10 to 12.2 kV with the outside wall of the capillary maintained at 42 °C. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference. Although only a few embodiments have been descπbed in detail above, those having ordinary skill in the relevant arts will clearly understand that many modifications are possible in the prefeπed embodiment without departing from the teachings thereof. All such modifications are intended to be encompassed within the following claims. VII. REFERENCES Andms, A. "Chemical methods for 5' non-isotopic labelling of PCR probes and pπmers" (1995) in PCR 2. A Practical Approach, Oxford University Press, Oxford, pp. 39- 54. Beaucage, S. and Iyer, R. "Advances in the synthesis of ohgonucleotides by the phosphoramidite approach", Tetrahedron 48:2223-2311 (1992). Bergot, B., Chakerian, V., Connell, C, Eadie, J., Fung, S., Hershey, N., Lee, L., Menchen, S. and Woo, S. "Spectrally resolvable rhodamine dyes for nucleic acid sequence determination", U.S. Patent 5,366,860, issued Nov. 22, 1994. Blackburn, G. and Gait, M. Eds. "DNA and RNA structure" in Nucleic Acids in Chemistry and Biology, 2 nd Edition, (1996) Oxford University Press. Breipohl, G., Will, D.W., Peyman, A. & Uhlmann, E. "Novel synthetic routes to PNA monomers and PNA-DNA linker molecules" Tetrahedron 53:14671-86 (1997). Bronstein, I. and Voyta, J , "Methods of using chemiluminescent 1,2-dιoxetanes" U.S. Patent 4,931,223, issued Jun. 5, 1990 Bronstein, K., Fortin, J., Stanley, P , Stewart, G and Kncka, L "Chemilummescent and bioluminescent reporter gene assays". Anal. Biochemistry 219 169-81 ( 1994) Buchardt, O , Egholm, M., Nielsen, P , and Berg, R "Peptide Nucleic Acids", WO 92/20702, Intl. Pub. Date 26 November 1992 Camthers, M. and Beaucage, S "Phosphoramidite compounds and processes", U.S Patent No 4,415,732, issued Nov 15, 1983 Camthers, M. and Matteucci, M "Process for prepanng polynucleotides", US Patent No. 4,458,066, issued July 3, 1984. Chirgwm, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W J., Biochemistry 18:5294-9 (1979). Clegg, R., "Fluorescence resonance energy transfer and nucleic acids", Meth. Enzymol., 21 1 :353-388 (1992). Corey, D "48000-fold Acceleration of hybπdization by chemically modified ohgonucleotides" J. Amer. Chem. Soc. 1 17:9373-74 (1995). Demers, D. "Method for enhancing amplification in the polymerase chain reaction employing peptide nucleic acid (PNA)" U.S. Patent No. 5,629,178, issued May 13, 1997. Egholm, M., Buchardt, O., Chnstensen, L., Behrens, C, Freier, S., Dπver, D., Berg, R. and Kim, S. "PNA hybridizes to complementary ohgonucleotides obeying the Watson-Crick hydrogen bonding rules", Nature 365:566-68 (1993). Egholm, M., Chnstensen, L., Dueholm, K., Buchardt, O., Coull, J., and Nielsen, P. "Efficient pH-independent sequence-specific DNA binding by pseudoisocytosine- contammg bis-PNA", Nucleic Acids Res. 23.217-22 (1995). Finn, P.J., Gibson, N.J., Fallon, R., Hamilton, A. & Brown, T. "Synthesis and properties of DNA-PNA Chimeric ohgomers" Nucleic Acids Research 24:3357-63 (1996). Flanagan, W., Wagner, R., Grant, D., Lm, K. and Matteucci, M. "Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide", Nature Biotech. 17-48-52 (1999). Goelet, P., Knapp, M., and Anderson, S "Method for determining nucleotide identity through pnmer extension" U.S. Patent No. 5,888,819, issued Mar. 30, 1999. Gong, B. and Yan, Y. "New DNA minor-groove binding molecules with high sequence- selectivities and binding affinities", Biochem. and Biophys. Res. Comm. 240:557- 60 (1997). Grossman, P., Fung, S , Menchen, S , Woo, S. and Winn-Deen. E "Probe composition containing a binding domain and polymer chain and methods of use" U.S Patent No 5,470,705, issued Nov 28, 1995. Hermanson, G. in Bioconjugate Techniques (1996) Academic Press, San Diego, pp 40- 55, 643-671. Khan. S , Menchen, S , Rosenblum, B. "Substituted propargylethoxyamido nucleosides, ohgonucleotides and methods for using same", U.S. Patent 5,770,716, issued Jun. 23, 1998, and "Propargylethoxyamino nucleotides", U S Patent 5,821,356, issued Oct. 13, 1998 Koch, J., Hmdkjaer, J , Mogensen, J., Kolvraa, S , and Bolund, L Genet. Anal. Tech Appl. 8.171-78 (1991). Kong, H., Kucera, R., Jack, W " Characteπzation of a DNA polymerase from the hyperthermophile archaea Thermococcus litorahs. Vent DNA polymerase, steady state kinetics, thermal stability, processivity, strand displacement, and exonuclease activities" J. Biol. Chem. 268:1965-75 (1993). Kncka, L. in Nonisotopic DNA Probe Techniques (1992), Academic Press, San Diego, pp. 3-28. Kubista, M. and Svanvik, N. "Probe for analysis of nucleic acids", WO 97/45539, Intl. Publ. Date Dec. 4, 1997. Kuhn, H., Demidov, V., Nielsen, P. and Frank-Kamenetskii, M. "An expenmental study of mechanism and specificity of peptide nucleic acid (PNA) binding to duplex DNA" Jour. Mol. Biol. 286:1337-45 (1999) Kutyavin, I., Lukhtanov, E., Gamper, H. and Meyer, R. "Covalently linked ohgonucleotide minor groove binder conjugates", WO 96/32496, Intl. Publ. Date Oct. 17, 1996. Kyger, E., Krevolm, M. and Powell, M. "Detection of the hereditary hemochromatosis gene mutation by real-time fluorescence polymerase chain reaction and peptide nucleic acid clamping", Anal. Biochem. 260:142-48 (1998). Lee, L., Connell, C, Woo, S., Cheng, R., McArdle, B., Fuller, C, Halloran, N. and Wilson, R. "DNA sequencing with dye-labeled terminators and T7 DNA polymerase: effect of dyes and dNTP on incorporation of dye-termmators and probability analysis of termination fragments", Nucleic Acids Res. 20:2471-83 (1992). Lee, L., Spurgeon, S., Rosenblum, B. "Energy transfer dyes with enhanced fluorescence", U.S. Patent No. 5,800,996, issued Sep. 1, 1998. Lee. R., Kaushik, N., Modak, M., Vinayak, R. and Pandey, V. "Polyamide nucleic acid targeted to the pπmer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcπption" Biochemistry 37:900-10 (1998). Lee. L, Graham, R., Mullah, B. and Haxo, F. "Nitro-substituted non- fluorescent asymmetπc cyanine dye compounds" U.S. Patent application No. 09/012,525, filed Jan. 23, 1998. Livak, K., Flood, S. and Marmaro, J. "Method for Detecting Nucleic Acid Amplification Using Self-Quenching Fluorescence Probe", U.S. Patent 5,538,848, issued July 23, 1996. Livak, K., Flood, S., Marmaro, J. and Mullah, K. "Self-quenching fluorescence probe", U.S. Patent 5,723,591, issued Mar. 3, 1998. Lutz, M.J., Bemier, S.A., Hein, S., Breipohl, G. & Uhlmann, E. "Recognition of uncharged polyamide-linked nucleic acid analogs by DNA polymerases and reverse transcriptatses" J. Am. Chem. Soc. 119:3177-78 (1997). Menchen, S., Lee, L., Connell, C, Hershey, N., Chakerian, V., Woo, S. and Fung, S. "4,7-Dichlorofluorescein dyes as molecular probes", U.S. patent 5,188,934, issued Feb. 23, 1993. Meyer, R. "Incorporation of modified bases in ohgonucleotides" in Protocols for Ohgonucleotide Conjugates, Ed. S. Agrawal (1994) Humana Press, Totowa, NJ, pp. 73-92. Misra, H., Pandey, P., Modak, M., Vinayak, R. and Pandey, V. "Polyamide nucleic acid- DNA chimera lacking the phosphate backbone are novel primers for polymerase reaction catalyzed by DNA polymerases" Biochemistry 37:1917-25 (1998). Mullis, K. "Process for amplifying nucleic acid sequences", U.S. Patent No. 4,683.202, issued Jul 28, 1987. Nielsen, P., Egholm, M., Berg, R. and Buchardt, O. "Sequence-selective recognition of DNA by strand displacement with a thymidine-substituted polyamide". Science 254:1497-1500 (1991). Nielsen, P. "Peptide nucleic acid (PNA): A lead for gene therapeutic drugs", Antisense Therapeutics 4:76-84 (1996). Rajur, S., Robles, J., Wiederholt, K., Kuimelis, R. and McLaughlin, L. "Hoechst 33258 tethered by a hexa(ethylene glycol) linker to the 5'-termιni of oligodeoxynucleotide 15-mers- duplex stabilization and fluorescence properties", J Organic Chem 62:523-29 (1997) Reeve, M. and Brown, T "Reagents comprising chimeπc molecules of nucleic acids and nucleic acid analogs" WO 95/08556, Intl Publ. Date 30 March 1995. Ross. P , Lee, K and Belgrader. P "Discπmination of single-nucleotide polymorphisms in human DNA using peptide nucleic acid probes detected by MALDI-TOF mass spectrometry" Anal Chem. 69-4197-4202 (1997) Sanger, F , Nicklen, S and Coulson, A. "DNA sequencing with cham-terminatmg inhibitors" Proc. Natl. Acad. Sci. USA 74:5463-5467 (1977). Smith, L., Kaiser, R., Sanders, J. and Hood, L. "The synthesis and use of fluorescent ohgonucleotides in DNA sequence analysis" Methods Enzymol. 155:260-301 (1987) Smith, L., Hood, L., Hunkapiller, M., Hunkapiller, T., and Connell, C. "Automated DNA sequencing technique" U.S. Patent No. 5,821,058, issued Oct. 13, 1998. Stanton, T., Schmdele, D., Renzoni, G., Pepich, B., Anderson, N., Clagett, J. and Opheim, K. "Preparation and use of monomeπc phthalocyanme reagents" WO 8804777, Intl. Publ. Date: June 30, 1988. Syvanen, A., Aaalto-Setala, K., Harju, L., Kontula, K. and Soderlund, H. "A pπmer- guided nucleotide incorporation assay in the genotypmg of apolipoprotem E" Genomics 8:684-92 (1990). Tabor, S. and Richardson, C, J. Biol. Chem. 264:6447-58 (1989). Uhlmann, E. "Peptide nucleic acids (PNA) and PNA-DNA chimera: from high binding affinity towards biological function" Biol Chem 379:1045-52 (1998). Uhlmann, E., Will, D., Breipohl, G., Langner, D. and Ryte, A. "Synthesis and properties of PNA-DNA chimera" Angew. Chem., Intl. Ed. Eng. 35:2632-35 (1996). Uhlmann, E., Breipohl, G., Benner, S., Lutz, M. "A nucleic acid amplification method using peptide nucleic acids as pnmers for thermostable DNA polymerases" EP 829542, Pπonty: Sept. 13, 1996. Van der Laan, A., Brill, R., Kuimehs, R., Kuyl-Yeheskiely, E., van Boom, J., Andms, A. and Vinayak, R "A convenient automated solid-phase synthesis of PNA-(5')-DNA- (3')-PNA chimera", Tetrahedron Lett. 38:2249-52 (1997). Van der Laan, A.C. et al "Optimization of the binding properties of PNA-(5')-DNA Chimerae" Bioorg. Med. Chem. Lett. 8.663-68 (1998). Vinayak, R., van der Laan, A., Brill, R., Otteson, K., Andms, A., Kuyl-Yeheskiely, E. and van Boom, J. "Automated chemical synthesis of PNA-DNA chimera on a nucleic synthesizer", Nucleosides & Nucleotides 16: 1653-56 (1997). Vinayak, R. "Process and compounds for RNA synthesis", U.S. Patent No. 5,281,701, issued Jan. 25, 1994. Von Matt, P., De Mesmaeker, A., Pieles. U., Zurcher, W. & Altmann, K.-H. "2'- deoxyribo-PNAs: a structurally novel class of polyamide nucleic acids with good RNA and DNA binding affinity" Tetrahedron Lett. 40:2899-2902 (1999). Wengel, J. "Ohgonucleotide analogs", WO 99/14226, Intl. Publ. Date 25 Mar. 1999. Will, D.W., Breipohl, G., Langner, D., Knolle, J. & Uhlmann, E. "The Synthesis of Polyamide Nucleic Acids using a Novel Monomethoxytrityl Protecting-Group Strategy" Tetrahedron 51 :12069-12082 (1995).

Claims: CLAIMS We claim 1 A method of producing a non-radioisotopically labelled chimenc extension product compπsmg the step of enzymatically extending a PNA-DNA chimera in the presence of a template nucleic acid, a polymerase and a pπmer extension reagent, wherein said pπmer extension reagent compπses a nucleotide 5'-tnphosphate capable of effecting enzymatic chimera pπmer extension, and wherein the chimera or the nucleotide 5 '-tπphosphate is labelled with a non-radioisotopic label 2 The method of claim 1 in which the PNA-DNA chimera has the stmcture. P x - L - N y 3' wherein each P is independently a PNA monomer, x is an integer from 5 to 15; L represents a covalent linkage between P and N, each N is independently a nucleotide, and y is an integer from 3 to 15; with the proviso that the 3' terminal N has a 3' hydroxyl group. 3 The method of claim 1 in which the pπmer extension reagent compnses a mixture of nucleotide 5 '-tπphosphates capable of effecting continuous pnmer extension 4 The method of claim 3 in which the mixture compnses four different nucleotide 5 '-tπphosphates, and further wherein a nucleotide 5 '-tπphosphate is ATP, dATP, 7-deaza dATP, 2-ammo-ATP or 2- ammo-dATP, and another nucleotide 5'-tnphosphate is GTP, dGTP, or 7-deaza dGTP, another nucleotide 5'-tnphosphate is CTP, dCTP, 5-methyl-CTP, 5-methyl-dCTP or 5-propynyl dCTP, and another nucleotide 5'-tπphosphate is UTP, dUTP, dTTP, 5-Br-UTP, 5-Br-dUTP. 5-F-UTP, 5-F-dUTP or 5-propynyl-dUTP 5 The method of claim 4 in which the mixture further includes a terminating nucleotide 5 '-tπphosphate 6 The method of claim 1 in which the nucleotide 5'-tπphosphate is a terminating nucleotide 5'-tπphosphate 7 The method of claim 5 or 6 in which the terminating nucleotide 5'- tnphosphate is detectably labelled with a fluorescent dye 8 The method of claim 1 in which the pπmer extension reagent further compπses a mixture of terminating nucleotide 5'-tnphosphates 9 The method of claim 8 in which the mixture compnses four different terminating nucleotide 5 '-tπphosphates, and further wherein a terminating nucleotide 5 '-tπphosphate is ddATP, 7-deaza ddATP, or 2',3'- dideoxy-dehydro-ATP, another terminating nucleotide 5 '-tπphosphate is ddGTP, 7-deaza ddGTP or 2',3'- dideoxy-dehydro-GTP, another terminating nucleotide 5 '-tπphosphate is ddCTP or 2',3'-dιdeoxy-dehydro- CTP, and another terminating nucleotide 5 '-tπphosphate is ddTTP, ddUTP, 2',3'-dιdeoxy- dehydro-TTP or 2',3'-dιdeoxy-dehydro-UTP 10 The method of claim 9 wherein each different terminating nucleotide 5'- tnphosphate is labelled with a different detectable label 11 The method of claim 2 wherein P x is a 2-ammoethylglycme peptide nucleic acid 12 The method of claim 2 in which each N is independently a 2'- deoxyπbonucleotide 13 The method of claim 2 m which each N is independently a nbonucleotide 14 The method of claim 2 wherein the nucleobases of N are selected from the group consisting of C-5-alkyl pyπmidme, 2,6-dιamιnopuπne, 2-fhιopynmιdιne, C-5- propyne pynmidine, phenoxazme, 7-deazapunne, isocytidme, pseudo-isocytidine, isoguanosine, hypoxanthine, 8-oxopuπne, and 4(3 H)-pyπmιdone 15. The method of claim 2 wherein the sugars of N are selected from the group consisting of 2'-0-alkyl-πbonucleotιdes, 2'-O-methyl-πbonucleotιdes, 2'-0-allyl- πbonucleotides, 2'-allyl πbonucleotides, 2'-halo-πbonucleotιdes, 2'-0-methoxyethyl- πbonucleotides, 4'-α-anomenc nucleotides, l'-α-anomeπc nucleotides, 2',4'-hnked nucleotides, and bicyc c nucleotides. 16 The method of claim 1 wherein the PNA-DNA chimera is labelled at the ammo terminus of the PNA moiety. 17. The method of claim 1 wherein the nucleotide 5'-tnphosphate is labelled at the nucleobase. 18. The method of claim 17 wherein the nucleobase label sites are the N-9 or C-8 positions of the puπne or deazapuπne, and the C-5 position of the pyπmidme. 19. The method of claim 1 wherein the label is selected from the group consisting of fluorescent dyes, fluorescence quenchers, hybridization-stabilizers, energy- transfer dye sets, electrophoretic mobility modifiers, chemiluminescent dyes, ammo acids, proteins, peptides, enzymes, and affinity ligands. 20. The method of claim 19 where the fluorescent dyes are selected from the group consisting of FAM, TET, HEX, JOE, TAMRA, d-TAMRA, JODA, ROX, VIC, NED. dJON, dR139, 4,7-dιchloro-fluoresceιns, 4,7-dιchloro-rhodammes, and cyanmes 21. The method of claim 19 where the fluorescence quenchers are selected from the group consisting of TAMRA, d-TAMRA, ROX, DABCYL, DABSYL, malachite green, NTB, and cyanines. 22. The method of claim 19 where the hybridization-stabilizers are minor groove binders. 23. The method of claim 19 where the minor groove binders are selected from the group consisting of Hoechst 33258, CDPIj -3 , MGBl, netropsm, and distamycm. 24. The method of claim 19 where the affinity ligands are selected from the group consisting of biotin, 2,4-dinitrophenyl, digoxigenm, cholesterol, polyethyleneoxy, peptides, and fluorescein. 25. The method of claim 2 wherein L is selected from the group consisting of a covalent bond, alkyldiyl consisting of 1-20 carbon atoms, aryldiyl, O linker, and - (CH?CH O) m - where m is 1 to 6. 26. The method of claim 1 in which the template nucleic acid is a DNA and ι the polymerase is selected from the group consisting of Klenow, T4, Bst, AmpliTaq, AmpliTaq Gold, AmpliTaq Stoffel fragment, Sequenase, Vent, Pfu, and bacteriophage T7. 27. The method of claim 1 in which the template nucleic acid is an RNA and the polymerase is a reverse transcriptase. 28. The method of claim 1 in which the template nucleic acid is a metaphase or interphase chromosome. 29. The method of claim 28 in which the chromosome is denatured. 30. The method of claim 1 in which the PNA-DNA chimera is immobilized on a solid substrate. 31. The method of claim 30 in which the chimera is covalently attached to the solid substrate, optionally with the aid of a linker. 32. The method of claim 1 in which the template nucleic acid is immobilized on a solid substrate. 33. The method of claim 32 in which the template nucleic acid is covalently attached to the solid substrate, optionally with the aid of a linker. 34. The method of claim 30 or 32 wherein the solid substrate is selected from the group consisting of polystyrene, controlled-pore-glass, silica gel, silica, polyacrylamide, magnetic beads, polyacrylate, hydroxyethylmethacrylate, polyamide, polyethylene, polyethyleneoxy, and copolymers and grafts of any of the above solid substrates. 35. The method of claim 30 or 32 wherein the solid substrate is selected from the group consisting of small particles, beads, membranes, frits, slides, plates, micromachined chips, alkanethiol-gold layers, non-porous surfaces, and polynucleotide- immobihzing media. 36. A kit for pπmer extension compπsing. a PNA-DNA chimera primer, said pnmer compnsmg 5 to 15 contiguous PNA monomer units, 3 to 15 contiguous nucleotides, and a 3' hydroxyl terminus; one or more nucleotide 5 '-tπphosphates and; a polymerase enzyme, wherein the chimera primer or a nucleotide 5'-tnphosphate is non- radioisotopically labelled. 37. The kit of claim 36 further comprising a template nucleic acid comprising a sequence complementary to the chimera primer or containing one or more mismatches to the chimera primer. 38. A method of sequencing a template nucleic acid, comprising the steps of: a. generating a labelled primer extension product by enzymatically extending a primer-template nucleic acid hybrid in the presence of a polymerase and a terminating nucleotide 5 '-triphosphate, wherein said primer is a PNA-DNA chimera and either said primer or said terminating nucleotide 5 '-triphosphate is detectably and non- radioisotopically labelled; b. separating the labelled primer extension products based on size; and c. determining the sequence of the template nucleic acid. 39. The method of claim 38 wherein a nested set of labelled primer extension products are generated by a mixture of enzymatically extendable nucleotide 5'- triphosphates capable of supporting continuous primer extension. 40. The method of claim 38 wherein the PNA-DNA chimera is labelled. 41. The method of claim 38 wherein the terminating nucleotide 5 '-triphosphate is labelled. 42. The method of claim 41 wherein the labelled, terminating nucleotide 5'- triphosphate is selected from the group consisting of a labelled ddNTP, a labelled 2'- amino, 2'-deoxynucleotide, a labelled 2'-halo, 2'-deoxynucleotide, and a labelled 2',3'- dideoxy-dehydronucleotide. 43 A method of reverse transcnption compπsing the step of generating labelled pπmer extension products by enzymatically extending a pπmer-template RNA hybπd in the presence of a reverse transcπptase, a mixture of enzymatically-extendable nucleotide 5 '-tπphosphates capable of supporting continuous pnmer extension, wherein said pπmer is a PNA-DNA chimera and either said pπmer or a nucleotide 5 '-tπphosphate is non-radioisotopically labelled. 44 A method of DNA amplification compπsing the steps of a generating labelled amplification products by enzymatically extending a pπmer-template nucleic acid hybπd in the presence of two pπmers each of which is capable of hybπdizing to the template and wherein one or both of which is a PNA-DNA chimera pπmer, a DNA polymerase and a mixture of enzymatically-extendable nucleotide 5 '-tπphosphates capable of supporting continuous pπmer extension, wherein either said pπmers or nucleotide 5 '-tπphosphates are non-radioisotopically labelled; and b. cycling the temperature to effect denaturation, annealing, and pπmer extension to form an amplification product by extension of the pπmers with nucleotide 5'- tπphosphates; wherein one or both of the 5' terminii of the amplification product bears the PNA sequence of the chimera pπmers. 45. The method of claim 44 in which the amplification product is immobilized by hybπdization on a solid substrate compnsmg a nucleic acid with a sequence complementary to the PNA sequence of the amplification product.

Inventors: CHEN CAIFU, EGHOLM MICHAEL, CHEN, CAIFU, EGHOLM, MICHAEL
Applicants: PE CORP, PE CORPORATION
Application year: 2000
Main classification: C12Q1
IPC codes: C12N15, C12Q1, G01N21, G01N33